Average Co-Inventor Count = 5.37
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sarcode Bioscience Inc. (10 from 25 patents)
2. Myokardia, Inc. (10 from 12 patents)
3. 3-v Biosciences, Inc. (8 from 10 patents)
4. Sunesis Pharmaceuticals, Inc. (6 from 63 patents)
5. Sarcode Corporation (4 from 4 patents)
6. Biogen Idec Ma Inc. (1 from 216 patents)
7. Sagimet Biosciences Inc. (1 patent)
38 patents:
1. 12344607 - Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases
2. RE50050 - Pyrimidinedione compounds
3. 11123337 - 4-methylsulfonyl-substituted piperidine urea compounds
4. 11034693 - Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases
5. 10758525 - 4-methylsulfonyl-substituted piperidine urea compounds
6. 10226449 - Heterocyclic modulators of lipid synthesis and combinations thereof
7. 10189822 - Heterocyclic modulators of lipid synthesis
8. 10124000 - Modulators of cellular adhesion
9. 10118913 - Heterocyclic modulators of lipid synthesis
10. 10053450 - Heterocyclic modulators of lipid synthesis
11. 9925177 - 4-methylsulfonyl-substituted piperidine urea compounds
12. 9809591 - Heterocyclic modulators of lipid synthesis
13. 9663516 - Bicyclic-pyrimidinedione compounds
14. 9624173 - Heterocyclic modulators of lipid synthesis
15. 9585883 - Pyrimidinedione compounds